With over 20 years of experience in higher education research and teaching, he has held significant roles of senior and principal investigator positions, showcasing a deep commitment to advancing academic knowledge and fostering a rich learning environment.
Holding a PhD in Biology & Biochemistry from the University of Bath, UK, he contributed to research at prestigious institutions like the Institute for Animal Health (now the Pirbright Institute), UK, the Edward Jenner Institute for Vaccine Research (now the Jenner Institute, Oxford) and Oxford Brookes University. Before pursuing his PhD, he earned two master’s degrees, one focused on Life Science, while the other specialized in Biotechnology. Actively participated in a project, notably at the prestigious ICGEB, a United Nations-affiliated institute in Prof. V. S. Chauhan (expert in peptide Chemistry/vaccine) laboratory, this expanded his academic horizons, paving the way for his PhD journey and shaping him into an accomplished scientist. His diverse career included positions at Zeneca, Evotec and Oxford Expression Technologies, demonstrating expertise in Life Sciences and Biotechnology.
In multidisciplinary research, he collaborated with distinguished scientists such as Prof. Sarah Gilbert (the inventor of the Covid vaccine), Prof. Mike Skinner (Imperial College, London) and Prof. Antony Parker (STFC, UK), and currently works with laser expert Prof. Stan Botchway (STFC, UK) on in-depth protein-protein interaction analysis, including SARS CoV-2, utilizing advanced techniques like fluorescence-FRET-FLIM. Previously, at AccendoLab Limited, London, he served as a scientific consultant and business development expert specialized in Covid testing.
Ananya has been the senior management team of the business development of DSK, and he is heading the European operations. He drives revenue growth and strategic partnerships, showcasing strong business development acumen.